Table 3.
Antimicrobial sensitivity of vaginal swab in National Health Laboratory (gram-negative species).
| Isolate, n (%) | Total (n = 133) | P value | ||||||
|---|---|---|---|---|---|---|---|---|
| Citrobacter spp. (n = 7) | E. coli (n = 87) | Klebsiella spp. (n = 19) | Other gram -ve (n = 14) | Proteus spp. (n = 6) | ||||
| Amikacin | I | 1 (14.3) | 15 (17.2) | 7 (36.8) | 1 (7.1) | 2 (33.3) | 26 (19.5) | 0.11 |
| R | 2 (28.6) | 6 (6.9) | 2 (10.5) | 0 (0.0) | 1 (16.7) | 11 (8.3) | ||
| S | 4 (57.1) | 66 (75.9) | 10 (52.6) | 13 (92.9) | 3 (50.0) | 96 (72.2) | ||
|
| ||||||||
| Cephalexin | I | 2 (28.6) | 39 (44.8) | 7 (36.8) | 2 (14.3) | 1 (16.7) | 51 (38.3) | 0.014 |
| R | 5 (71.4) | 20 (23.0) | 4 (21.1) | 8 (57.1) | 4 (66.7) | 41 (30.8) | ||
| S | 0 (0.0) | 28 (32.2) | 8 (42.1) | 4 (28.6) | 1 (16.7) | 41 (30.8) | ||
|
| ||||||||
| Ceftazidime | I | 0 (0.0) | 6 (6.9) | 2 (10.5) | 1 (7.1) | 0 (0.0) | 9 (6.8) | 0.039 |
| R | 3 (42.9) | 7 (8.0) | 3 (15.8) | 4 (28.6) | 3 (50.0) | 20 (15.0) | ||
| S | 4 (57.1) | 74 (85.1) | 14 (73.7) | 9 (64.3) | 3 (50.0) | 104 (78.2) | ||
|
| ||||||||
| Ceftriaxone | I | 2 (28.6) | 3 (3.4) | 0 (0.0) | 2 (14.3) | 0 (0.0) | 7 (5.3) | 0.060 |
| R | 2 (28.6) | 12 (13.8) | 3 (15.8) | 2 (14.3) | 2 (33.3) | 21 (15.8) | ||
| S | 3 (42.9) | 72 (82.8) | 16 (84.2) | 10 (71.4) | 4 (66.7) | 105 (78.9) | ||
|
| ||||||||
| Nalidixic acid | I | 1 (14.3) | 5 (5.7) | 4 (21.1) | 2 (14.3) | 1 (16.7) | 13 (9.8) | 0.253 |
| R | 3 (42.9) | 20 (23.0) | 4 (21.1) | 2 (14.3) | 3 (50.0) | 32 (24.1) | ||
| S | 3 (42.9) | 62 (71.3) | 11 (57.9) | 10 (71.4) | 2 (33.3) | 88 (66.2) | ||
|
| ||||||||
| Ampicillin | I | 1 (14.3) | 9 (10.3) | 3 (15.8) | 1 (7.1) | 0 (0.0) | 14 (10.1) | 0.85 |
| R | 5 (71.4) | 58 (66.7) | 15 (78.9) | 11 (78.6) | 11 (78.6) | 100 (71.9) | ||
| S | 1 (14.3) | 20 (23.0) | 1 (5.3) | 2 (14.3) | 1 (16.7) | 25 (18) | ||
|
| ||||||||
| Chloramphenicol | I | 0 (0.0) | 1 (1.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.8) | 0.01 |
| R | 2 (28.6) | 7 (8.0) | 3 (15.8) | 3 (21.4) | 3 (50.0) | 18 (14) | ||
| S | 5 (71.4) | 79 (90.8) | 16 (84.2) | 11 (78.6) | 3 (50.0) | 114 (85.7) | ||
|
| ||||||||
| Ciprofloxacin | I | 2 (28.6) | 5 (5.7) | 1 (5.3) | 0 (0.0) | 0 (0.0) | 8 (6) | 0.001 |
| R | 1 (14.3) | 10 (11.5) | 2 (10.5) | 2 (14.3) | 3 (50.0) | 18 (14) | ||
| S | 4 (57.1) | 72 (82.8) | 16 (84.2) | 12 (85.7) | 3 (50.0) | 107 (80.5) | ||
|
| ||||||||
| Trimethoprim-sulfamethoxazole | I | 1 (14.3) | 2 (2.3) | 2 (10.5) | 1 (7.1) | 0 (0.0) | 6 (4.5) | 0.225 |
| R | 2 (28.6) | 43 (49.4) | 7 (36.8) | 4 (28.6) | 5 (83.3) | 61 (46) | ||
| S | 4 (57.1) | 42 (48.3) | 10 (52.6) | 9 (64.3) | 1 (16.7) | 66 (49.6) | ||
|
| ||||||||
| Gentamicin | I | 1 (14.3) | 13 (14.9) | 4 (21.1) | 1 (7.1) | 2 (33.3) | 21 (15.8) | 0.001 |
| R | 3 (42.9) | 20 (23.0) | 4 (21.1) | 1 (7.1) | 3 (50.0) | 31 (23) | ||
| S | 3 (42.9) | 54 (62.1) | 11 (57.9) | 12 (85.7) | 1 (16.7) | 81 (60.9) | ||
|
| ||||||||
| Nitrofurantoin | I | 1 (14.3) | 6 (6.9) | 1 (5.3) | 4 (28.6) | 1 (16.7) | 13 (9.8) | 0.001 |
| R | 0 (0.0) | 8 (9.2) | 9 (47.4) | 4 (28.6) | 4 (66.7) | 25 (19) | ||
| S | 6 (85.7) | 73 (83.9) | 9 (47.4) | 6 (42.9) | 1 (16.7) | 95 (71.4) | ||
|
| ||||||||
| Tetracycline | I | 1 (14.3) | 3 (3.4) | 0 (0.0) | 1 (7.1) | 0 (0.0) | 5 (3.8) | 0.328 |
| R | 3 (42.9) | 45 (51.7) | 9 (47.4) | 6 (42.9) | 6 (100.0) | 69 (51.9) | ||
| S | 3 (42.9) | 39 (44.8) | 10 (52.6) | 7 (50.0) | 0 (0.0) | 59 (44.4) | ||
I: intermediate; R: resistant: S: sensitive.